Totesora Darwin, Chua-Agcaoili Ma Theresa
Section of Endocrinology, Diabetes and Metabolism, The Medical City, Pasig City, Philippines.
J ASEAN Fed Endocr Soc. 2019;34(2):215-219. doi: 10.15605/jafes.034.02.14. Epub 2019 Nov 9.
Cystic nodule is an unusual presentation of Papillary Thyroid Carcinoma (PTC), seen in less than 10% of cases. Even by ultrasound, finding a thyroid cyst carries a less than 5% chance of malignancy. We present a case of a 45-year-old male, who came in for incidental finding of a palpable thyroid mass with no significant predisposing history. Thyroidectomy was done and immunohistochemical staining confirmed it to be papillary thyroid cancer. He underwent high dose radiation therapy with post therapy whole body scan showing no evidence of radioavid foci aside from the thyroid bed. The malignant potential of cystic nodule(s) should never be overlooked in certain select patients even if it carries a low chance of malignancy. The diagnosis of PTC relies primarily on the typical nuclear features, however in cases of histologic uncertainty, immunohistochemical stains such as HBME-1 may be used to help classify unusual presentations of PTC. Treatment and monitoring of Cystic Papillary Thyroid Carcinoma follows the conventional guideline on solid PTC.
囊性结节是甲状腺乳头状癌(PTC)的一种不常见表现,见于不到10%的病例。即使通过超声检查,发现甲状腺囊肿的恶性几率也低于5%。我们报告一例45岁男性病例,他因偶然发现可触及的甲状腺肿块前来就诊,无明显的易感病史。进行了甲状腺切除术,免疫组化染色证实为甲状腺乳头状癌。他接受了高剂量放射治疗,治疗后全身扫描显示除甲状腺床外无放射性浓聚灶的证据。即使囊性结节的恶性几率较低,但在某些特定患者中,其恶性潜能绝不应被忽视。PTC的诊断主要依赖于典型的核特征,然而在组织学不确定的情况下,免疫组化染色如HBME-1可用于帮助对PTC的不常见表现进行分类。囊性甲状腺乳头状癌的治疗和监测遵循实性PTC的常规指南。